Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
from NDTV News - Topstories https://ift.tt/3iFD1JW
Subscribe to:
Post Comments (Atom)
-
While some have the confidence and the ability to showcase their sensuality, there are others who are more secretive about it than you may t...
-
Amazon Prime Day 2025 sale is now live. The three-day shopping event includes hundreds of great deals on top smartphones, laptops, TVs, and ...
No comments:
Post a Comment